Several patients treated with IL-1 blocking agents have had improvement in their anemia but none have had repeat bone marrow biopsies to determine if the dyserythropoeisis which is a classic part of the disease is reversed with IL-1 blockade. This evidence concerns the gene IL1B and anemia (phenotype).